These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


226 related items for PubMed ID: 23774118

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pathological changes in the pancreas of fulminant type 1 diabetes and slowly progressive insulin-dependent diabetes mellitus (SPIDDM): innate immunity in fulminant type 1 diabetes and SPIDDM.
    Kobayashi T, Nishida Y, Tanaka S, Aida K.
    Diabetes Metab Res Rev; 2011 Nov; 27(8):965-70. PubMed ID: 22069294
    [Abstract] [Full Text] [Related]

  • 3. RIG-I- and MDA5-initiated innate immunity linked with adaptive immunity accelerates beta-cell death in fulminant type 1 diabetes.
    Aida K, Nishida Y, Tanaka S, Maruyama T, Shimada A, Awata T, Suzuki M, Shimura H, Takizawa S, Ichijo M, Akiyama D, Furuya F, Kawaguchi A, Kaneshige M, Itakura J, Fujii H, Endo T, Kobayashi T.
    Diabetes; 2011 Mar; 60(3):884-9. PubMed ID: 21289206
    [Abstract] [Full Text] [Related]

  • 4. Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes.
    Tanaka S, Nishida Y, Aida K, Maruyama T, Shimada A, Suzuki M, Shimura H, Takizawa S, Takahashi M, Akiyama D, Arai-Yamashita S, Furuya F, Kawaguchi A, Kaneshige M, Katoh R, Endo T, Kobayashi T.
    Diabetes; 2009 Oct; 58(10):2285-91. PubMed ID: 19641142
    [Abstract] [Full Text] [Related]

  • 5. Unique Inflammatory Changes in Exocrine and Endocrine Pancreas in Enterovirus-Induced Fulminant Type 1 Diabetes.
    Takita M, Jimbo E, Fukui T, Aida K, Shimada A, Oikawa Y, Yagihashi S, Miura J, Babazono T, Kobayashi T.
    J Clin Endocrinol Metab; 2019 Oct 01; 104(10):4282-4294. PubMed ID: 31112279
    [Abstract] [Full Text] [Related]

  • 6. Expression of toll-like receptors in the pancreas of recent-onset fulminant type 1 diabetes.
    Shibasaki S, Imagawa A, Tauriainen S, Iino M, Oikarinen M, Abiru H, Tamaki K, Seino H, Nishi K, Takase I, Okada Y, Uno S, Murase-Mishiba Y, Terasaki J, Makino H, Shimomura I, Hyöty H, Hanafusa T.
    Endocr J; 2010 Oct 01; 57(3):211-9. PubMed ID: 20009359
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets.
    Suarez-Pinzon W, Sorensen O, Bleackley RC, Elliott JF, Rajotte RV, Rabinovitch A.
    Diabetes; 1999 Jan 01; 48(1):21-8. PubMed ID: 9892218
    [Abstract] [Full Text] [Related]

  • 9. Different diabetogenic potential of autoaggressive CD8+ clones associated with IFN-gamma-inducible protein 10 (CXC chemokine ligand 10) production but not cytokine expression, cytolytic activity, or homing characteristics.
    Ejrnaes M, Videbaek N, Christen U, Cooke A, Michelsen BK, von Herrath M.
    J Immunol; 2005 Mar 01; 174(5):2746-55. PubMed ID: 15728483
    [Abstract] [Full Text] [Related]

  • 10. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells.
    Ylipaasto P, Klingel K, Lindberg AM, Otonkoski T, Kandolf R, Hovi T, Roivainen M.
    Diabetologia; 2004 Feb 01; 47(2):225-39. PubMed ID: 14727023
    [Abstract] [Full Text] [Related]

  • 11. Expression of chemokines, CXC chemokine ligand 10 (CXCL10) and CXCR3 in the inflamed islets of patients with recent-onset autoimmune type 1 diabetes.
    Uno S, Imagawa A, Saisho K, Okita K, Iwahashi H, Hanafusa T, Shimomura I.
    Endocr J; 2010 Feb 01; 57(11):991-6. PubMed ID: 20966598
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction.
    Chong MM, Chen Y, Darwiche R, Dudek NL, Irawaty W, Santamaria P, Allison J, Kay TW, Thomas HE.
    J Immunol; 2004 May 01; 172(9):5714-21. PubMed ID: 15100317
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Identification of T cell subsets and class I and class II antigen expression in islet grafts and pancreatic islets of diabetic BioBreeding/Worcester rats.
    Weringer EJ, Like AA.
    Am J Pathol; 1988 Aug 01; 132(2):292-303. PubMed ID: 3135758
    [Abstract] [Full Text] [Related]

  • 20. Pancreatic beta and alpha cells are both decreased in patients with fulminant type 1 diabetes: a morphometrical assessment.
    Sayama K, Imagawa A, Okita K, Uno S, Moriwaki M, Kozawa J, Iwahashi H, Yamagata K, Tamura S, Matsuzawa Y, Hanafusa T, Miyagawa J, Shimomura I.
    Diabetologia; 2005 Aug 01; 48(8):1560-4. PubMed ID: 15991022
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.